Delivery Order SPE2DR25D3015-SPE2DR26F4FB4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on September 23, 2025, with an ultimate completion date of October 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price contract structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is listed as the vendor's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a $26,282.34 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units). This is a firm fixed-price contract with an ultimate completion date of January 2, 2026, and no set-aside designation was utilized in the award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor fulfilling this order under its broader...
- The Defense Logistics Agency awarded a $8,313.12 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit of use packaging). This firm fixed-price contract, with a completion date of September 25, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition...
- The Defense Logistics Agency awarded a $4.38K delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for ORGOVYX 120 mg tablets (30-count units) with performance in Conshohocken, Pennsylvania and completion by November 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency awarded a $8,313.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit dose) with an ultimate completion date of October 16, 2025. The contract is non-competitive with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,760.78 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on November 13, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 on July 29, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) under a firm fixed-price contract valued at $1,385.52, with an ultimate completion date of October 8, 2025. This non-set-aside award reflects competitive procurement through open competition and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,460.13 and an ultimate completion date of November 19, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FB4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30s. The contract, executed on December 2, 2025, with an ultimate completion date of December 23, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates competitively awarded delivery orders across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. As the prime contractor under the DLA Medical Supply Chain vehicle, AmerisourceBergen continues to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with potential involvement in future Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/1/25 |